Eyenovia Deferred Long Term Liab vs Total Assets Analysis

EYEN Stock

USD 1.92 0.01 0.52%

Eyenovia financial indicator trend analysis is much more than just examining Eyenovia latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eyenovia is a good investment. Please check the relationship between Eyenovia Deferred Long Term Liab and its Total Assets accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.

Deferred Long Term Liab vs Total Assets

Deferred Long Term Liab vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eyenovia Deferred Long Term Liab account and Total Assets. At this time, the significance of the direction appears to have pay attention.

The correlation between Eyenovia's Deferred Long Term Liab and Total Assets is -0.93. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Total Assets in the same time period over historical financial statements of Eyenovia, assuming nothing else is changed. The correlation between historical values of Eyenovia's Deferred Long Term Liab and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Eyenovia are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Deferred Long Term Liab i.e., Eyenovia's Deferred Long Term Liab and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.93

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Total Assets

Total assets refers to the total amount of Eyenovia assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Eyenovia books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most indicators from Eyenovia's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eyenovia current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.At this time, Eyenovia's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 17th of February 2025, Enterprise Value is likely to grow to about 7.9 B, while Selling General Administrative is likely to drop about 7.3 M.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	307.4K	783.2K	900.7K	945.7K
Interest Income	83.3K	547.6K	629.7K	661.2K

Depreciation And Amortization Interest Income

Eyenovia fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Other Assets	Retained Earnings Total Equity	Deferred Long Term Liab	Net Invested Capital
Total Assets		0.59	0.89	0.87	0.93	0.65	-0.44	-0.89	0.94	0.94	0.7	0.94	0.94	0.76	0.94	0.68	0.87	0.86	0.61	0.97	0.84	0.81	0.72	-0.97	-0.93	0.95
Other Current Liab	0.59		0.82	0.48	0.38	0.1	-0.69	-0.35	0.43	0.7	0.09	0.7	0.51	0.25	0.51	0.26	0.34	0.54	0.09	0.7	0.33	0.21	0.05	-0.54	-0.49	0.32
Total Current Liabilities	0.89	0.82		0.69	0.73	0.48	-0.47	-0.73	0.77	0.84	0.59	0.84	0.82	0.62	0.81	0.56	0.7	0.82	0.47	0.88	0.69	0.63	0.51	-0.83	-0.76	0.73
Total Stockholder Equity	0.87	0.48	0.69		0.84	0.38	-0.65	-0.68	0.85	0.93	0.53	0.93	0.81	0.51	0.83	0.37	0.68	0.61	0.33	0.89	0.63	0.63	0.55	-0.9	-0.9	0.85
Net Tangible Assets	0.93	0.38	0.73	0.84		0.81	-0.23	-0.94	0.93	0.86	0.83	0.86	0.96	0.88	0.97	0.8	0.96	0.9	0.78	0.88	0.94	0.9	0.85	-0.96	-0.95	0.96
Property Plant And Equipment Net	0.65	0.1	0.48	0.38	0.81		0.33	-0.9	0.65	0.46	0.87	0.46	0.8	0.98	0.79	0.98	0.93	0.89	0.99	0.56	0.94	0.91	0.92	-0.68	-0.64	0.75
Net Debt	-0.44	-0.69	-0.47	-0.65	-0.23	0.33		0.04	-0.38	-0.67	0.24	-0.67	-0.25	0.19	-0.28	0.25	-0.02	-0.06	0.37	-0.58	0.03	0.11	0.24	0.42	0.45	-0.22
Retained Earnings	-0.89	-0.35	-0.73	-0.68	-0.94	-0.9	0.04		-0.87	-0.76	-0.86	-0.76	-0.96	-0.95	-0.95	-0.9	-0.98	-0.94	-0.87	-0.82	-0.98	-0.95	-0.9	0.92	0.87	-0.92
Accounts Payable	0.94	0.43	0.77	0.85	0.93	0.65	-0.38	-0.87		0.88	0.69	0.88	0.92	0.73	0.93	0.65	0.86	0.79	0.63	0.9	0.83	0.76	0.68	-0.95	-0.97	0.92
Cash	0.94	0.7	0.84	0.93	0.86	0.46	-0.67	-0.76	0.88		0.49	1.0	0.87	0.59	0.88	0.52	0.74	0.75	0.42	0.99	0.71	0.64	0.52	-0.94	-0.93	0.83
Non Current Assets Total	0.7	0.09	0.59	0.53	0.83	0.87	0.24	-0.86	0.69	0.49		0.49	0.81	0.91	0.8	0.81	0.88	0.83	0.87	0.56	0.89	0.94	0.95	-0.72	-0.66	0.83
Cash And Short Term Investments	0.94	0.7	0.84	0.93	0.86	0.46	-0.67	-0.76	0.88	1.0	0.49		0.87	0.59	0.88	0.52	0.74	0.75	0.42	0.99	0.71	0.64	0.52	-0.94	-0.93	0.83
Common Stock Total Equity	0.94	0.51	0.82	0.81	0.96	0.8	-0.25	-0.96	0.92	0.87	0.81	0.87		0.89	1.0	0.81	0.96	0.94	0.77	0.91	0.95	0.91	0.83	-0.97	-0.94	0.93
Common Stock Shares Outstanding	0.76	0.25	0.62	0.51	0.88	0.98	0.19	-0.95	0.73	0.59	0.91	0.59	0.89		0.88	0.97	0.97	0.95	0.97	0.67	0.98	0.96	0.94	-0.79	-0.73	0.83
Capital Surpluse	0.94	0.51	0.81	0.83	0.97	0.79	-0.28	-0.95	0.93	0.88	0.8	0.88	1.0	0.88		0.8	0.96	0.93	0.76	0.91	0.94	0.9	0.81	-0.97	-0.95	0.93
Other Current Assets	0.68	0.26	0.56	0.37	0.8	0.98	0.25	-0.9	0.65	0.52	0.81	0.52	0.81	0.97	0.8		0.92	0.93	0.97	0.61	0.94	0.88	0.86	-0.7	-0.64	0.73
Other Stockholder Equity	0.87	0.34	0.7	0.68	0.96	0.93	-0.02	-0.98	0.86	0.74	0.88	0.74	0.96	0.97	0.96	0.92		0.96	0.91	0.8	1.0	0.96	0.91	-0.9	-0.86	0.91
Total Liab	0.86	0.54	0.82	0.61	0.9	0.89	-0.06	-0.94	0.79	0.75	0.83	0.75	0.94	0.95	0.93	0.93	0.96		0.88	0.82	0.96	0.9	0.83	-0.86	-0.8	0.84
Property Plant And Equipment Gross	0.61	0.09	0.47	0.33	0.78	0.99	0.37	-0.87	0.63	0.42	0.87	0.42	0.77	0.97	0.76	0.97	0.91	0.88		0.51	0.93	0.89	0.89	-0.65	-0.61	0.71
Total Current Assets	0.97	0.7	0.88	0.89	0.88	0.56	-0.58	-0.82	0.9	0.99	0.56	0.99	0.91	0.67	0.91	0.61	0.8	0.82	0.51		0.78	0.71	0.6	-0.95	-0.93	0.87
Common Stock	0.84	0.33	0.69	0.63	0.94	0.94	0.03	-0.98	0.83	0.71	0.89	0.71	0.95	0.98	0.94	0.94	1.0	0.96	0.93	0.78		0.96	0.91	-0.88	-0.84	0.89
Property Plant Equipment	0.81	0.21	0.63	0.63	0.9	0.91	0.11	-0.95	0.76	0.64	0.94	0.64	0.91	0.96	0.9	0.88	0.96	0.9	0.89	0.71	0.96		0.98	-0.83	-0.76	0.91
Other Assets	0.72	0.05	0.51	0.55	0.85	0.92	0.24	-0.9	0.68	0.52	0.95	0.52	0.83	0.94	0.81	0.86	0.91	0.83	0.89	0.6	0.91	0.98		-0.74	-0.67	0.87
Retained Earnings Total Equity	-0.97	-0.54	-0.83	-0.9	-0.96	-0.68	0.42	0.92	-0.95	-0.94	-0.72	-0.94	-0.97	-0.79	-0.97	-0.7	-0.9	-0.86	-0.65	-0.95	-0.88	-0.83	-0.74		0.98	-0.94
Deferred Long Term Liab	-0.93	-0.49	-0.76	-0.9	-0.95	-0.64	0.45	0.87	-0.97	-0.93	-0.66	-0.93	-0.94	-0.73	-0.95	-0.64	-0.86	-0.8	-0.61	-0.93	-0.84	-0.76	-0.67	0.98		-0.9
Net Invested Capital	0.95	0.32	0.73	0.85	0.96	0.75	-0.22	-0.92	0.92	0.83	0.83	0.83	0.93	0.83	0.93	0.73	0.91	0.84	0.71	0.87	0.89	0.91	0.87	-0.94	-0.9

Click cells to compare fundamentals

Eyenovia Account Relationship Matchups

Eyenovia fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	33.9M	31.7M	31.0M	28.8M	33.1M	21.0M
Other Current Liab	16.6M	2.4M	2.3M	1.9M	2.2M	3.3M
Total Current Liabilities	18.2M	11.2M	4.5M	9.5M	11.0M	6.2M
Total Stockholder Equity	15.3M	20.5M	17.2M	9.0M	10.3M	12.4M
Net Tangible Assets	16.9M	11.7M	15.3M	20.5M	23.5M	24.7M
Property Plant And Equipment Net	396.4K	1.3M	3.3M	5.0M	5.8M	6.1M
Net Debt	(27.9M)	(12.3M)	(12.7M)	1.2M	1.1M	1.2M
Retained Earnings	(77.4M)	(90.2M)	(118.2M)	(145.5M)	(130.9M)	(124.4M)
Accounts Payable	1.5M	1.6M	1.4M	1.8M	2.0M	1.2M
Cash	28.4M	19.5M	22.9M	14.8M	17.1M	16.0M
Non Current Assets Total	515.4K	9.7M	3.4M	8.1M	9.3M	9.7M
Cash And Short Term Investments	28.4M	19.5M	22.9M	14.8M	17.1M	16.0M
Common Stock Shares Outstanding	21.1M	26.3M	33.6M	41.0M	47.2M	49.5M
Liabilities And Stockholders Equity	33.9M	31.7M	31.0M	28.8M	33.1M	21.0M
Other Current Assets	2.1M	734.9K	3.6M	5.1M	5.9M	6.2M
Other Stockholder Equity	92.7M	110.7M	135.5M	154.5M	177.7M	186.5M
Total Liab	18.6M	11.2M	13.8M	19.8M	22.7M	23.9M
Property Plant And Equipment Gross	396.4K	1.6M	3.3M	7.2M	8.2M	8.7M
Total Current Assets	33.4M	22.0M	27.6M	20.7M	23.8M	18.3M
Common Stock	2.5K	2.8K	3.7K	4.6K	5.2K	5.5K
Property Plant Equipment	36.7K	230.5K	396.4K	1.3M	1.5M	1.5M
Non Currrent Assets Other	119.0K	511.0K	80.9K	908.6K	1.0M	1.1M
Non Current Liabilities Total	404.5K	19.9K	9.3M	10.2M	11.8M	12.4M
Inventory	1.6M	730.4K	3.6M	109.8K	126.3K	120.0K
Net Invested Capital	15.8M	27.6M	26.0M	23.3M	26.8M	19.9M
Net Working Capital	15.2M	10.8M	23.1M	11.2M	12.9M	14.7M
Capital Stock	2.5K	2.8K	3.7K	4.6K	5.2K	3.0K
Short Long Term Debt Total	463.4K	7.2M	10.1M	16.1M	18.5M	19.4M
Net Receivables	3.1M	2.1M	1.8M	624.5K	562.1K	534.0K
Short Term Debt	97.5K	7.2M	833.8K	5.8M	6.7M	7.0M

Pair Trading with Eyenovia

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eyenovia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will appreciate offsetting losses from the drop in the long position's value.

Moving against Eyenovia Stock

0.48	BMY	Bristol Myers Squibb	Pair Corr
0.42	LNTH	Lantheus Holdings Earnings Call This Week	Pair Corr
0.35	MRK	Merck Company	Pair Corr

The ability to find closely correlated positions to Eyenovia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eyenovia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eyenovia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eyenovia to buy it.

The correlation of Eyenovia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyenovia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyenovia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Eyenovia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Eyenovia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eyenovia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eyenovia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eyenovia Stock:

How To Invest In Eyenovia

Details

Is Eyenovia Stock a good investment?

Details

What is Eyenovia's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.

You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(55.20)

Revenue Per Share

0.047

Quarterly Revenue Growth

0.356

Return On Assets

(0.80)

Return On Equity

(3.88)

The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Eyenovia Deferred Long Term Liab vs Total Assets Analysis

Deferred Long Term Liab vs Total Assets

Deferred Long Term Liab vs Total Assets Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Total Assets

Eyenovia fundamental ratios Correlations

Eyenovia Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Eyenovia fundamental ratios Accounts

Pair Trading with Eyenovia

Moving against Eyenovia Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Capital Surpluse	+ 1.0	Common Stock Total Equity
Common Stock	+ 1.0	Other Stockholder Equity
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments

Common Stock	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Retained Earnings Total Equity	- 0.97	Capital Surpluse
Retained Earnings Total Equity	- 0.97	Common Stock Total Equity
Deferred Long Term Liab	- 0.97	Accounts Payable
Retained Earnings Total Equity	- 0.97	Total Assets